Lars Rickard Backsell
Chairman chez Entreprenörskapsforum
Profil
Lars Rickard Backsell was the founder and Chairman of Recipharm AB, which was founded in 1994.
He is currently the Chairman of Entreprenörskapsforum, Deputy Director of Recipharmfastigheter AB, Director of Rohirrim AB, Director of B&E Invest AB, Director of Cajelo Invest AB, Director of Cajelo AB, Director of NorthX Biologics Matfors AB, and a Member of the Royal Swedish Academy of Engineering Sciences.
Mr. Backsell's former positions include Chief Executive Officer of Coloplast AB from 1981 to 1985, Chief Executive Officer of Recip AB from 1995 to 2007, Chairman of B&E Participation AB, Chairman of Backsell Eldered Holding AB, Sales Director of Coloplast A from 1986 to 1991, Director of BioInvent International AB from 2010 to 2012, Director of Aros Growth Capital AB, Director of Skärmare Drifts AB, and Business Area Manager of Pharmacia AB from 1991 to 1995.
He received his undergraduate degree from Stockholm School of Economics in 1978.
Postes actifs de Lars Rickard Backsell
| Sociétés | Poste | Début |
|---|---|---|
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Corporate Officer/Principal | 12/05/2010 |
| Rohirrim AB | Director/Board Member | - |
| B&E Invest AB | Director/Board Member | - |
| Recipharmfastigheter AB | Corporate Officer/Principal | - |
| Entreprenörskapsforum | Chairman | - |
| Cajelo Invest AB | Director/Board Member | - |
Cajelo AB
 Cajelo AB Financial ConglomeratesFinance Cajelo AB provides financial intermediation and business consulting services. The private company is based in Stockholm, Sweden. | Director/Board Member | - |
NorthX Biologics Matfors AB
 NorthX Biologics Matfors AB BiotechnologyHealth Technology NorthX Biologics Matfors AB is a biologics company that specializes in high-quality protein production and DNA manufacturing. The company is based in Matfors, Sweden, and has subsidiaries in Sweden. The Swedish company offers comprehensive cell banking services, including master cell bank production, GMP cell banking, and cell bank characterization, ensuring quality and compliance for biological products. The company also provides premium plasmid DNA services, offering GMP, High Quality, and Research Grade plasmids for gene therapy, cell therapy, molecular biology research, and clinical applications. The company was founded in 1963, and Janet Hoogstraate has been the CEO of the company since 2023. | Director/Board Member | 14/06/2022 |
Anciens postes connus de Lars Rickard Backsell
| Sociétés | Poste | Fin |
|---|---|---|
Recip AB
 Recip AB Pharmaceuticals: MajorHealth Technology Part of Viatris, Inc., Recip AB is a private company that manufactures pharmaceutical products. Recip AB is based in Arsta, Sweden. Recip was acquired by Meda AB, part of Viatris, Inc. from August 24, 2016 on December 31, 2007 for $475.65 million. | Chief Executive Officer | 01/01/2007 |
| ░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Lars Rickard Backsell
| Stockholm School of Economics | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| COLOPLAST A/S | Health Technology |
| BIOINVENT INTERNATIONAL AB | Health Technology |
| Entreprise privées | 17 |
|---|---|
Recipharm AB
 Recipharm AB BiotechnologyHealth Technology Recipharm AB engages in the manufacture of pharmaceuticals and contract development services for pharmaceutical companies. It operates through the following segments: Manufacturing Sterile and Inhalation (MFG-SI); Manufacturing Solids and Others (MFG-SO); Development and Technology (D&T); and Others and Eliminations. The MFG-SI segment includes manufacturing of products on behalf of pharmaceutical companies and covers sterile and inhalation technologies as well as liquid vials and ampoules, lyophilisates, blow-fill-seal products, and inhalation. The MFG-SO segment produces products on behalf of pharmaceutical companies and covers tablets, capsules, semi-solids, and non-sterile liquids. The D&T segment focuses on pharmaceutical development services. The company was founded by Lars Rickard Backsell and Thomas Bengt Eldered in 1995 and is headquartered in Stockholm, Sweden. | Health Technology |
| Pharmacia AB | Health Technology |
Royal Swedish Academy of Engineering Sciences
Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Commercial Services |
B&E Participation AB
 B&E Participation AB Pharmaceuticals: MajorHealth Technology B&E Participation AB manufactures and provides pharmaceuticals, natural medicines, dietary supplements, and medical supplies. The company was founded on February 6, 1995 and is headquartered in Årsta, Sweden. | Health Technology |
Coloplast AB
 Coloplast AB Medical DistributorsDistribution Services Coloplast AB develops and markets medical products and services. It focuses on the urinary and gastrointestinal tract systems. The company is headquartered in Kungsbacka, Sweden. | Distribution Services |
Recip AB
Recip AB Pharmaceuticals: MajorHealth Technology Part of Viatris, Inc., Recip AB is a private company that manufactures pharmaceutical products. Recip AB is based in Arsta, Sweden. Recip was acquired by Meda AB, part of Viatris, Inc. from August 24, 2016 on December 31, 2007 for $475.65 million. | Health Technology |
| Entreprenörskapsforum | |
| Recipharmfastigheter AB | |
| Aros Growth Capital AB | |
| Rohirrim AB | |
| Skärmare Drifts AB | |
| Backsell Eldered Holding AB | Finance |
| B&E Invest AB | |
| Cajelo Invest AB | |
Cajelo AB
Cajelo AB Financial ConglomeratesFinance Cajelo AB provides financial intermediation and business consulting services. The private company is based in Stockholm, Sweden. | Finance |
Hovås Invest Aktiebolag
 Hovås Invest Aktiebolag Financial ConglomeratesFinance Hovås Invest Aktiebolag is a private company based in Gothenburg, Sweden. The Swedish company provides investment services. | Finance |
NorthX Biologics Matfors AB
NorthX Biologics Matfors AB BiotechnologyHealth Technology NorthX Biologics Matfors AB is a biologics company that specializes in high-quality protein production and DNA manufacturing. The company is based in Matfors, Sweden, and has subsidiaries in Sweden. The Swedish company offers comprehensive cell banking services, including master cell bank production, GMP cell banking, and cell bank characterization, ensuring quality and compliance for biological products. The company also provides premium plasmid DNA services, offering GMP, High Quality, and Research Grade plasmids for gene therapy, cell therapy, molecular biology research, and clinical applications. The company was founded in 1963, and Janet Hoogstraate has been the CEO of the company since 2023. | Health Technology |
